trending Market Intelligence /marketintelligence/en/news-insights/trending/MYik_p6_jPrXUYH8cHcmJg2 content esgSubNav
Log in to other products


Looking for more?

Contact Us
In This List

G Medical Innovations files for $17M Nasdaq IPO


Climate Credit Analytics: Linking climate scenarios to financial impacts


Global M&A Infographic Q1 2021


Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge


COVID-19 Impact & Recovery: Private Equity

G Medical Innovations files for $17M Nasdaq IPO

G Medical Innovations Holdings Ltd. is looking to raise up to $17.3 million in an IPO of its American depositary shares.

The mobile and e-health company applied to list its ADSs on the Nasdaq Capital Market under the GMVD symbol.

G Medical noted that its shares will remain listed on the Australian Securities Exchange and will be dual listed on Nasdaq following U.S. IPO completion.

H.C. Wainwright & Co. LLC is acting as underwriter and sole running manager in the U.S. offering.

Cayman Islands-based G Medical is an early-stage commercial healthcare company that develops mobile and e-health solutions as well as monitoring platforms for patients with cardiovascular disease, pulmonary disease and diabetes.